Skip to main content

Table 3 List of vaccine priority groups other than health care workers, essential service providers, high risk individuals and healthy adults/children

From: Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review

  EE GR IE IT JP MT RO SK SE UK US N = 11 (100%)
Reported by countries as specific vaccine priority group             
Long term care facility residentsA        X      1 (9%)
Individuals living in "closed communities" (e.g. nursing homes)A . X1 . . . .    . . . 1 (9%)
Individuals in crowding area (e.g. schools) . X1 . . . . . . . . . 1 (9%)
Staff of workplaces where many people gather (e.g. banks, shops) . . . . . . . X . . . 1 (9%)
"Selected age groups, depending on national and/or WHO advice"B . . X .   X . . . X . 3 (27%)
Selected industries (e.g. pharmaceuticals)C . . X .   . . . . X . 2 (18%)
(Sub) groups not clearly categorized as belonging to main groups             
Pandemic vaccine manufacturersD . . . X2 . . X4 . . . X5 3 (27%)
Household contacts of immunocompromised personsE . . . . . . . X . . X 2 (18%)
Household contacts of high-risk patients X . . . . . . . X . . 2 (18%)
Household contacts of children . . . . . . . . . . X 1 (9%)
Seniors      X3        1 (9%)
  1. A Specified as additional vaccine priority group to the "high risk individuals"; while in other countries these individuals may be included in seasonal vaccination group; B Vaccination policy might be revised in the event of one or more age groups being more severely affected in a pandemic; C Reported as separate vaccine priority group; while in other countries these individuals might have been included, but had not been listed, under the "essential workers"; D Countries have specifically reported this (sub) group while in other countries these might have been included, but had not been listed, under "essential workers"; E This category also includes "family members of persons with impaired immunity" (SK); 1 Currently in the process of discussing and refining further priority groups, information in the table includes "suggested" priority groups as published in the National Pandemic Plan; 2 Not listed in National Pandemic Plan, but updated information received from country representative; 3 Reported as separate vaccine priority groups in draft guidelines; 4 Specified as separate (1 of 6) vaccine priority group; 5 Specified as 'subtier' belonging to one of four 'tiers' and includes also antiviral manufacturers